ICD-10-CM Billable Code

C84.16

Sézary disease, intrapelvic lymph nodes

Clinical Classification Guidelines

Medical Intelligence & Overview

Sézary disease is a rare type of cutaneous T-cell lymphoma, a cancer of the lymphatic system that primarily affects the skin. When it involves intrapelvic lymph nodes, it indicates that the cancer has spread from the skin to lymph nodes located within the pelvic region. This condition can present unique challenges in diagnosis and management due to its involvement of deep lymphatic structures. Recognizing the signs and understanding the underlying causes can help in early detection and appropriate treatment planning.

Causes & Symptoms

Clinical Causes: Genetic mutations affecting T-cell immunity Chronic exposure to environmental toxins or chemicals Infections that stimulate immune dysregulation Family history of lymphomas or other hematologic cancers Immune system suppression or compromised immunity

Key Symptoms: Persistent or unusual skin rashes, often erythroderma (red, inflamed skin) Intense itching and peeling of the skin Lymphadenopathy, especially in the pelvic area (swollen lymph nodes) Fatigue and weakness Weight loss and loss of appetite Recurrent infections due to immune suppression Fluid buildup or swelling in the legs if lymphatic flow is obstructed

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a combination of clinical examination, skin biopsies, and laboratory tests: - **Skin biopsy:** Tissue samples from affected skin reveal characteristic atypical T-cells. - **Blood tests:** Peripheral blood smear and flow cytometry to identify abnormal T-cell populations. - **Imaging studies:** CT scans or PET scans to assess the extent of lymph node involvement, particularly in the pelvis. - **Lymph node biopsy:** Confirming infiltration by malignant T-cells in intrapelvic lymph nodes. - **Molecular studies:** T-cell receptor gene rearrangement testing to establish clonality and malignancy. Accurate staging is essential for determining the extent of disease spread and forming a treatment plan.

Treatment Protocols: Management of Sézary disease with pelvic lymph node involvement typically involves a multidisciplinary approach: - **Skin-directed therapies:** Topical corticosteroids, phototherapy, or radiation therapy to control skin symptoms. - **Systemic treatments:** Chemotherapy regimens, biological agents such as monoclonal antibodies, and targeted therapies aimed at malignant T-cells. - **Immunotherapy:** Treatments like extracorporeal photopheresis, which modulates immune responses. - **Stem cell transplant:** In suitable candidates, high-dose chemotherapy followed by autologous or allogeneic stem cell transplantation might be considered. - **Supportive care:** Managing infections, maintaining skin integrity, and addressing nutritional needs. Since Sézary disease is a chronic condition, ongoing monitoring and adjustments in therapy are usually necessary to manage symptoms and control disease progression.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C84.16 a billable ICD-10 code?
Yes, C84.16 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C84.16?
Clinical documentation must specify the nature of Sézary disease, intrapelvic lymph nodes and any associated comorbidities for accurate reporting.

Cite this Clinical Reference